Glutamate-like receptors (GLRs) in plants play an important role in a number of physiological processes, including wound response, stomatal aperture control, seed germination, root development, innate immune responses, pollen tube growth and morphogenesis. GLRs share amino acid sequence similarity with ionotropic glutamate receptors (iGluRs) that mediate neurotransmission in the nervous system of vertebrates. In contrast to iGluRs, however, for which numerous full-length structures are available, the structural information about the plant GLRs has been missing. Here we determine crystal structures of Arabidopsis thaliana GLR3. 
Introduction
Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels that mediate excitatory neurotransmission throughout the vertebrate central nervous system (CNS) (Kumar and Mayer, 2013; Traynelis et al., 2010) . iGluRs assemble of 4 subunits, each containing four main domains:
amino-terminal domain (ATD) implicated in receptor assembly, trafficking and regulation; ligandbinding domain (LBD or S1S2) that harbors binding sites for agonists, antagonists and, allosteric modulators; transmembrane domain (TMD) forming an ion channel; and the cytosolic carboxyterminal domain (CTD), which is involved in receptor localization and regulation (Twomey and Sobolevsky, 2018) . The neurotransmitter glutamate activates iGluR by binding to the LBD and inducing conformational changes that ultimately lead to the opening of the ion channel (Armstrong and Gouaux, 2000; Twomey and Sobolevsky, 2018) . Based on pharmacology, iGluRs have been classified into four subtypes: AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), NMDA (N-methyl-D-aspartate), kainate and δ-receptors (Traynelis et al., 2010) . Interestingly, homologs of mammalian iGluRs have been identified in both vascular and non-vascular plants and are known as glutamate-like receptors (GLRs) (Lam et al., 1998) .
Recent studies identified vital roles of GLRs in various physiological processes in plants,
including the response to wounding, stomatal aperture control, seed germination, root development, innate immunity responses, pollen tube growth and morphogenesis (Kong et al., 2016; Kong et al., 2015; Li et al., 2013; Michard et al., 2011; Mousavi et al., 2013; Singh et al., 2016) . Different number of GLRs are found in genomes of plants, including 20 for Arabidopsis thaliana, 2 for moss, 9 for ginkgo, 40 for pine and, 13 for tomato (Aouini et al., 2012; De Bortoli et al., 2016; Ortiz-Ramirez et al., 2017; Price et al., 2012; Wudick et al., 2018b) . Arabidopsis thaliana GLRs (AtGLRs) are phylogenetically divided into 3 different clades (Chiu et al., 2002; Lacombe et al., 2001; Wudick et al., 2018a) . AtGLR3.2, a representative of the third clade, was found localized in the plasma membrane (Vincill et al., 2013) . Since overexpression of AtGLR3.2 in transgenic plants resulted in Ca 2+ deprivation that was rescued by exogeneous Ca 2+ application, AtGLR3.2 was proposed to function as an ion channel (Kim et al., 2001) .
While GLRs govern a broad range of physiological and pathophysiological processes in plants, the molecular mechanisms underlying their function, including AtGLR3.2, remain elusive.
To gain insight into how plant GLRs bind to their activating ligands, we embarked on studies of AtGLR3.2 LBD.
Results and discussion

Structure determination
In order to determine the LBD structure , we used Arabidopsis thaliana GLR3.2 (AtGLR3.2) DNA to make a crystallizing construct GLR3.2-S1S2. The boundaries of the two segments, S1 and S2, that assemble into the ligand-binding domain were determined based on the amino acid sequence alignment of AtGLR3.2 with the mammalian iGluRs (Supplementary Figure 1) . Also included in the GLR3.2-S1S2 construct were 46 residues N-terminal to the beginning of S1 that have not been resolved in our crystal structures and presumably remain disordered. We expressed the GLR3.2-S1S2 construct in bacteria and purified the protein using affinity and ion-exchange chromatography (see Methods). Size-exclusion chromatography depicted the purified protein to be in monomeric form. The crystals of GLR3.2-S1S2 grew in the presence of methionine and glycine in sitting and hanging drops of vapor diffusion crystallization trays and were cryoprotected using glycerol for diffraction data collection at the synchrotron. Crystals of GLR3.2-S1S2 grown in the presence of glycine and methionine belonged to the P212121 space group, contained one S1S2 protomer in the asymmetric unit and diffracted to 1.57 and 1.86 Å resolution, respectively (Supplementary Table 1 ). We solved the GLR3.2-S1S2Gly and GLR3.2-S1S2Met structures by molecular replacement, initially using a homology modeled search probe (see Methods). The clarity of the resulting electron density maps were sufficient (Supplementary Figure 2) for building the structural models that included residues G47 to N286, with a 108 residue-long S1 GT-linked to a 130 residue-long S2.
The structures of approximately 57x37x35 Å 3 in dimension have a bilobed clamshell architecture ( Figure 1a -b), with the ligand-binding site between the upper D1 lobe and the lower D2 lobe, similar to the iGluR LBDs (Gouaux, 2004) . The GLR3.2-S1S2Gly and GLR3.2-S1S2Met structures superpose very well with the root mean square deviation (RMSD) of 0.275 Å for Cα atoms. Despite the GLR3.2-S1S2Gly and GLR3.2-S1S2Met backbone similarity, several residues show different side chain orientations, including Asp68, Lys132, Glu145, Arg159 and Arg281, with the greatest difference in side-chain rotamers observed for Arg281. For the ligand-binding pocket, however, side-chain orientations are very similar between GLR3.2-S1S2Gly and GLR3.2-S1S2Met.
Ligand binding
The and Roberts, 2014; Kong et al., 2016; Michard et al., 2011; Tapken et al., 2013; Vincill et al., 2012; Vincill et al., 2013; Wudick et al., 2018a) . Such promiscuity has never been observed in iGluRs.
The binding pocket and the mode of ligand binding, however, might be somewhat different between GLRs. For example, Trp, Phe and Tyr can serve as agonists of AtGLR1.4 but not AtGLR3.3 or AtGLR3.4 (Tapken et al., 2013; Vincill et al., 2012; Vincill et al., 2013) suggesting that the ligand-binding pocket in AtGLR1.4 is likely larger and can accommodate bulky hydrophobic side chains.
Comparison of GLR3.2 and iGluR LBD structures
The GLRs share poor sequence identity to iGluRs, nevertheless, the structural fold of their LBDs is highly conserved. However, there are some major structural differences between the GLR and iGluR LBDs. For structural comparison, we superimposed the GLR3.2 LBD with the previously solved agonist-bound LBD structures of GluA1 (Armstrong and Gouaux, 2000) , GluK2 (Mayer, 2005) , GluN1 (Furukawa and Gouaux, 2003) and GluN2A (Furukawa et al., 2005) . The overall LBD fold is quite similar between GLR3.2 and iGluRs. The RMSD value for all Cα atoms is 1.9, 1.8, 1.5 and 4.5 Å for GluA1, GluN1, GluK2 and GluN2, respectively. In all iGluRs, the highly conserved and structurally important disulfide bond formed between the regions C-terminal to helices I and K is also present in the GLR3.2 LBD and connects Cys230 to Cys284. Compared to iGluR LBDs, however, the GLR3.2 LBD is missing the β-hairpin loop between β2 and helix C.
Neither GLR3.2 LBD has the helix G. Instead, this region adopts a short β strand that we named 9b. The loop between β1 and helix B is shorter in GLR in comparison to GluN1 (1PB7), GluK2
(1S50) and GluN2A (2A5S). This region harbors the ligand-binding Arg57 residue. In addition, NMDA receptor LBDs also have a loop between β1 and helix B, forming a large hairpin, which is missing in GLR3.2 as well as AMPA and kainate receptor LBDs.
Critically, the extent of the LBD clamshell closure around the ligand is very similar in LBDs of GLR3.2 and all agonist-bound iGluRs. This suggests that both glycine and methionine play a role of agonists or partial agonists of GLR3.2, which may explain previous reports of GLRs (GLR3.1/3.5) as L-Met-activated Ca 2+ channels responsible for maintaining cytosolic Ca 2+ (Kong et al., 2016) . Accordingly, the LBD captured in our GLR3.2-S1S2Gly and GLR3.2-S1S2Met structures might act similar to the LBD in iGluRs by opening their clamshell in the absence of a ligand and closing it in its presence, where the clamshell closure provides a driving force to gate an ion channel (Armstrong and Gouaux, 2000; Twomey and Sobolevsky, 2018) . To test this hypothesis, one would need to capture the full-length structure of GLR. The predicted similarity in the LBD clamshell architecture, ligand binding and gating mechanism also suggests that plant GLRs and iGluRs originated from a common ancestor to function in different kingdoms of life but utilizing similar molecular mechanisms.
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Methods
Construct
DNA for Arabidopsis thaliana GLR3.2 was a gift of Prof. José A. Feijó (University of Maryland).
The boundaries of the GLR3.2 ligand-binding domain (S1S2) were determined based on the sequence alignment with GluA2 (Armstrong et al., 1998; Sobolevsky et al., 2009 ). The DNA encoding AtGLR3.2 residues Ser420-V572 (S1) and P682-N811 (S2) was amplified using genespecific primers and subcloned into the pET22b vector (Novagen) between NcoI and XhoI sites with a GT linker between S1 and S2 (Armstrong and Gouaux, 2000) . For purifications purposes, 8xHis affinity tag followed by a thrombin cleavage site (LVPRG) were introduced N-terminally.
Protein expression and purification
The construct pET22b carrying GLR3.2-S1S2 was transformed into Escherichia coli Origami B (DE3) cells and grown in LB media supplemented with 100 µg/ml ampicillin, 15 µg/ml kanamycin and 12.5 µg/ml tetracycline. The freshly inoculated culture was grown at 37°C until OD600 reached the value of 1.0-1.2. Then cells were cooled down to 20°C, induced with 250 µM IPTG and incubated in the orbital shaker for another 20 hours at 20°C. Cells were harvested by centrifugation at 5000 rpm for 15 min at 4°C and the cell pellet was washed with the buffer containing 20 mM Tris pH 8.0 and 150 mM NaCl. For protein extraction, cells were resuspended in lysis buffer consisting of 20 mM Tris pH 8.0, 200 mM NaCl, 1 mM glutamate, 5 mM methionine, 1 mM ME, 1 mM PMSF, 100 µg/ml lysozyme, 5 mM MgSO4 and DNAse. All purification steps were carried out in buffers supplemented with 1 mM glutamate and 5 mM methionine. The cells were disrupted by sonication and centrifuged at 40,000 rpm in the Ti45 rotor for 1 hour at 4°C. The supernatant was mixed with His60 Ni superflow resin (Takara) and rotated for 2 hours at 4°C. The proteinbound resin was washed with the buffer containing 15 mM imidazole and the protein was eluted in 20 mM Tris pH 8.0, 150 mM NaCl, 1 mM glutamate, 5 mM methionine, 1 mM ME, and 200 mM Imidazole. The protein was dialyzed overnight in the buffer containing 20 mM Tris pH 8.0, 75 mM NaCl, 1 mM glutamate, 5 mM methionine, 1 mM BME, and 4% glycerol. After thrombin digest (1:500 w/w) at 22°C for 1-hour, the protein was further purified using ion-exchange HiTrap Q HP-(GE Healthcare). The protein quality was assessed by SDS-PAGE and analytical sizeexclusion chromatography using the Superpose 10/300 column (GE Healthcare).
Crystallization and structure determination
Crystallization screening was performed with GLR3.2-S1S2 protein at a concentration of ~7 mg/ml using Mosquito robot (TTP Labtech) and sitting drop vapor diffusion in 96-well crystallization plates. Small needle-shaped crystals, which appeared after two weeks of incubating crystallization trays at 4°C and 20°C, were further optimized using the hanging drop method and 24-well crystallization plates. The best-diffracting long needle-shaped crystals of methioninebound GLR3.2-S1S2 grew at 20°C in 0.1 M MES pH 6.5, 18% PEG MME 2K and 0.1 M ammonium sulfate. Crystals of glycine-bound GLR3.2-S1S2 grew in a similar condition but in the presence of 0.3 µl of 1M glycine that supplemented the 4µl crystallization drop as an additive. The best-diffracting needle-shaped crystals of glycine-bound GLR3.2-S1S2 grew at 4°C in 22 % PEG 4K, 0.1 M ammonium acetate, and 0.1 M sodium acetate pH 4.6. All crystals were cryoprotected using 25% glycerol and flash-frozen in liquid nitrogen for data collection. Crystal diffraction data were collected at the beamline 24-ID-C of the Advanced Photon Source and processed using XDS (Kabsch, 2010) and Aimless as a part of the CCP4 suite (Winn et al., 2011) .
The structure of methionine-bound GLR3.2-S1S2 was solved by molecular replacement using Phaser (McCoy, 2007) and a search probe generated by SWISS-MODEL homology modeling (Waterhouse et al., 2018) from the ligand-binding domain of NMDA receptor (PDB ID:
6MMS) (Jalali-Yazdi et al., 2018) . The initial partial solution was used again as a search probe for subsequent rounds of molecular replacement, which ultimately resulted in a complete GLR3.2-S1S2 model. The model was refined by alternating cycles of building in COOT (Emsley and Cowtan, 2004 ) and automatic refinement in Phenix (Adams et al., 2010) . The structure of glycinebound GLR3.2-S1S2 was solved by molecular replacement using the methionine-bound GLR3.2-S1S2 structure as a search probe. Water molecules were added in Coot and Phenix refine. All structural figures were prepared in PyMol (DeLano, 2002) .
Data Availability
Model coordinates have been deposited to the Protein Data Bank (PDB) under accession numbers XXXX for GLR3.2-S1S2 structure in complex with glycine and YYYY in complex with methionine. All other data are available from the corresponding author upon request. Secondary structure elements for GLR3.2-S1S2 are shown as cylinders (α-helices), arrows (β-strands) and lines (loops) colored according to domains S1 (orange and purple) and S2 (red and green). The names of α-helices and β-strands (capital letters and numbers, respectively) are kept the same as in structures of isolated LBD (Armstrong et al., 1998) 
